Drug
Regn 2cat
Regn 2cat: highest development phase Phase 3, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| REGN-2Cat NCT07675811 | Phase 3 | Allergic Conjunctivitis |
Latest
No recent events.
Follow Regn 2cat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.